These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34518918)

  • 41. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
    Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.
    Paranjpe I; Chaudhary K; Johnson KW; Jaladanki SK; Zhao S; De Freitas JK; Pujdas E; Chaudhry F; Bottinger EP; Levin MA; Fayad ZA; Charney AW; Houldsworth J; Cordon-Cardo C; Glicksberg BS; Nadkarni GN
    PLoS One; 2021; 16(2):e0247366. PubMed ID: 33626098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
    Santos Bravo M; Nicolás D; Berengua C; Fernandez M; Hurtado JC; Tortajada M; Barroso S; Vilella A; Mosquera MM; Vila J; Marcos MA
    J Infect Dis; 2021 Oct; 224(8):1325-1332. PubMed ID: 34329473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies-The First Single-Centre Experience from the Czech Republic.
    Čerňan M; Szotkowski T; Minařík J; Kolář M; Sauer P; Látal V; Zapletalová J; Papajík T
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).
    Sharpley FA; Larham J; Haines A; Djebbari F; Tseu B; Leary H; Vallance G; Panitsas F; Ferguson L; Roberts P; Peniket A; Gooding S; Kothari J; Moore S; Ramasamy K
    Br J Haematol; 2021 Mar; 192(6):e136-e139. PubMed ID: 33326594
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China.
    Zhu X; Jiang Q; Lu J; Sun Y; Zhao X; Yang S; Tang F; Yu W; Zhao T; Liu X; Jia J; Duan W; Hu L; Wang J; Liu Y; Peng N; Dou X; Ma R; Fu Q; Wang H; Liu K; Huang X; Jiang H
    Br J Haematol; 2023 Jul; 202(1):31-39. PubMed ID: 37092433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Description of Epidemiological Features, Symptoms and Mortality of the Patients with COVID-19 in Some Provinces of Iran.
    Khosravi Shadmani F; Amanollahi A; Zali A; Najafi F; Karami M; Moradi G; Mohammadian-Hafshejani A; Ahmadi A; Sartipi M; Shojaeian M; Noori E; Javaheri M; Bahadorimonfared A; Hashemi-Nazari SS
    Arch Iran Med; 2021 Oct; 24(10):733-740. PubMed ID: 34816694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
    Saji R; Nishii M; Sakai K; Miyakawa K; Yamaoka Y; Ban T; Abe T; Ohyama Y; Nakajima K; Hiromi T; Matsumura R; Suzuki N; Taniguchi H; Otsuka T; Oi Y; Ogawa F; Uchiyama M; Takahashi K; Iwashita M; Kimura Y; Fujii S; Furuya R; Tamura T; Ryo A; Takeuchi I
    PLoS One; 2021; 16(8):e0256022. PubMed ID: 34379684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.
    Lin A; He ZB; Zhang S; Zhang JG; Zhang X; Yan WH
    Clin Infect Dis; 2020 Nov; 71(16):2061-2065. PubMed ID: 32337591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
    J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.
    Ranzani OT; Bastos LSL; Gelli JGM; Marchesi JF; Baião F; Hamacher S; Bozza FA
    Lancet Respir Med; 2021 Apr; 9(4):407-418. PubMed ID: 33460571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies.
    Wu Y; Chen W; Li W; Zhao M; Wei Q; Zhang X; Mei H; Wang Y; Hu Y
    Leuk Lymphoma; 2020 Dec; 61(14):3440-3450. PubMed ID: 32840399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
    Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
    Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
    Glenthøj A; Jakobsen LH; Sengeløv H; Ahmad SA; Qvist K; Rewes A; Poulsen CB; Overgaard UM; Mølle I; Severinsen MT; Strandholdt CN; Maibom J; Kodahl AR; Ryg J; Ravn P; Johansen IS; Helsø SN; Jensen-Fangel S; Kisielewicz J; Wiese L; Helleberg M; Kirk O; Clausen MR; Frederiksen H
    Eur J Haematol; 2021 Jan; 106(1):72-81. PubMed ID: 32939853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.
    Niu A; Ning B; Socola F; Safah H; Reynolds T; Ibrahim M; Safa F; Alfonso T; Luk A; Mushatt DM; Hu T; Saba NS
    Leuk Res; 2021 Jul; 106():106582. PubMed ID: 33933714
    [No Abstract]   [Full Text] [Related]  

  • 57. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.
    Laracy JC; Kamboj M; Vardhana SA
    Curr Opin Infect Dis; 2022 Aug; 35(4):271-279. PubMed ID: 35849516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
    Lahmer T; Salmanton-García J; Marchesi F; El-Ashwah S; Nucci M; Besson C; Itri F; Jaksic O; Čolović N; Weinbergerová B; Seval GC; Adžić-Vukičević T; Szotkowski T; Sili U; Dargenio M; van Praet J; van Doesum J; Schönlein M; Ráčil Z; Žák P; Poulsen CB; Magliano G; Jiménez M; Bonuomo V; Piukovics K; Dragonetti G; Demirkan F; Blennow O; Valković T; Gomes Da Silva M; Maertens J; Glenthøj A; Fernández N; Bergantim R; Verga L; Petzer V; Omrani AS; Méndez GA; Machado M; Ledoux MP; Bailén R; Duarte RF; Del Principe MI; Farina F; Martín-Pérez S; Dávila-Valls J; Marchetti M; Bilgin YM; Fracchiolla NS; Cattaneo C; Espigado I; Cordoba R; Collins GP; Labrador J; Falces-Romero I; Prezioso L; Meers S; Passamonti F; Buquicchio C; López-García A; Kulasekararaj A; Ormazabal-Vélez I; Cuccaro A; Garcia-Vidal C; Busca A; Navrátil M; de Jonge N; Biernat MM; Guidetti A; Abu-Zeinah G; Samarkos M; Anastasopoulou A; de Ramón C; González-López TJ; Hoenigl M; Finizio O; Pinczés LI; Ali N; Vena A; Tascini C; Stojanoski Z; Merelli M; Emarah Z; Kohn M; Barać A; Mladenović M; Mišković B; Ilhan O; Çolak GM; Čerňan M; Gräfe SK; Ammatuna E; Hanakova M; Víšek B; Cabirta A; Nordlander A; Nunes Rodrigues R; Hersby DS; Zambrotta GPM; Wolf D; Núñez-Martín-Buitrago L; Arellano E; Aiello TF; García-Sanz R; Prattes J; Egger M; Limongelli A; Bavastro M; Cvetanoski M; Dibos M; Rasch S; Rahimli L; Cornely OA; Pagano L;
    Infection; 2024 Jun; 52(3):1125-1141. PubMed ID: 38388854
    [No Abstract]   [Full Text] [Related]  

  • 59. [Features of COVID-19 infection among patients with hematological malignancies].
    Fissore G; Skog S; Lastra J; Chandía M
    Rev Med Chil; 2022 May; 150(5):625-633. PubMed ID: 37906763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of COVID 19 on red flag discussions for haematological malignancies within the Belfast trust.
    Waddell D; Benson G
    Ulster Med J; 2021 May; 90(2):77-80. PubMed ID: 34276084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.